Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes

被引:193
作者
Meng, F. [1 ,2 ]
Wehbe-Janek, H. [2 ]
Henson, R. [2 ]
Smith, H. [2 ]
Patel, T. [1 ,2 ]
机构
[1] Ohio State Univ, Med Ctr, Coll Med, Dept Internal Med, Columbus, OH 43210 USA
[2] Texas A&M Univ, Coll Med, Syst Hlth Sci Ctr, Scott & White Clin,Dept Internal Med, Temple, TX 76508 USA
关键词
noncoding RNA; cytokine; liver cancer;
D O I
10.1038/sj.onc.1210648
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL-6) is overexpressed and contributes to tumor cell growth in cholangiocarcinoma. Enforced IL-6 production can alter the expression of specific microRNAs ( miRNAs) involved in tumor growth, and moreover can modulate expression of methylation-dependent genes. Thus, we assessed the methylation-dependent regulation of miRNA expression in human malignant cholangiocytes stably transfected to overexpress IL-6. The expression of the methyltransferases DNA methyltransferase enzyme-1 and HASJ4442 was increased by IL-6 overexpression, but was decreased by the methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-CdR). Expression pro. ling identified seven miRNAs that were significantly downregulated by IL-6 overexpression (<0.4-fold) and upregulated (>2- fold) by 5-aza-CdR. One of these, miR-370, is embedded in a CpG island. Although 5-aza-CdR increased miR-370 expression by 2.1-fold in malignant cells, the expression in nonmalignant cells was unchanged. The oncogene mitogen- activated protein kinase kinase kinase 8 (MAP3K8) was identified as a target of miR-370, and its expression was decreased by 5-aza-CdR in cholangiocarcinoma cells. Overexpression of IL-6 reduced miR-370 expression and reinstated MAP3K8 expression in vitro as well as in tumor cell xenografts in vivo. Thus, IL-6 may contribute to tumor growth by modulation of expression of selected miRNAs, such as miR-370. These studies de. ne a mechanism by which inflammation-associated cytokines can epigenetically modulate gene expression and directly contribute to tumor biology.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 31 条
[1]  
AOKI M, 1993, J BIOL CHEM, V268, P22723
[2]   Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues [J].
Bandres, E. ;
Cubedo, E. ;
Agirre, X. ;
Malumbres, R. ;
Zarate, R. ;
Ramirez, N. ;
Abajo, A. ;
Navarro, A. ;
Moreno, I. ;
Monzo, M. ;
Garcia-Foncillas, J. .
MOLECULAR CANCER, 2006, 5 (1)
[3]   Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells [J].
Banerjee, A ;
Gugasyan, R ;
McMahon, M ;
Gerondakis, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) :3274-3279
[4]   DNA methylation and gene silencing in cancer [J].
Baylin S.B. .
Nature Clinical Practice Oncology, 2005, 2 (Suppl 1) :S4-S11
[5]   MicroRNAs and chromosomal abnormalities in cancer cells [J].
Calin, G. A. ;
Croce, C. M. .
ONCOGENE, 2006, 25 (46) :6202-6210
[6]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[7]   Multiple mitogen-activated protein kinase signaling pathways connect the Cot oncoprotein to the c-jun promoter and to cellular transformation [J].
Chiariello, M ;
Marinissen, MJ ;
Gutkind, JS .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1747-1758
[8]   The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-κB signaling downstream of TRAF2 [J].
Eliopoulos, AG ;
Davies, C ;
Blake, SSM ;
Murray, P ;
Najafipour, S ;
Tsichlis, PN ;
Young, LS .
JOURNAL OF VIROLOGY, 2002, 76 (09) :4567-4579
[9]   Principles of interleukin (IL)-6-type cytokine signalling and its regulation [J].
Heinrich, PC ;
Behrmann, I ;
Haan, S ;
Hermanns, HM ;
Müller-Newen, G ;
Schaper, F .
BIOCHEMICAL JOURNAL, 2003, 374 (01) :1-20
[10]   Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation [J].
Hodge, DR ;
Peng, B ;
Cherry, JC ;
Hurt, EM ;
Fox, SD ;
Kelley, JA ;
Munroe, DJ ;
Farrar, WL .
CANCER RESEARCH, 2005, 65 (11) :4673-4682